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a b s t r a c t
Cyclin-dependent kinases (CDKs) have an established role in metazoans and yeast in DNA replica-
tion, transcription and cell cycle regulation. Several CDKs and their effectors have been identified in
the malaria parasite Plasmodium falciparum and their biological functions are beginning to be investi-
gated. Here we report results from the functional characterization of Pfmrk and its effector PfMAT1.
We validated the interactions between Pfmrk and PfMAT1 and pinpointed their intracellular location.
Co-immunoprecipitation studies demonstrated physical interaction between the two proteins and iden-
tified the C-terminal domain of PfMAT1 as the Pfmrk activator domain. Immunofluorescence analyses
using GFP and RFP-tagged versions of Pfmrk and PfMAT1, respectively, demonstrated the co-localization
of these two proteins to the parasite nucleus. Bacterial two-hybrid screen of a P. falciparum cDNA library
using Pfmrk as the bait identified two plasmodial DNA replication proteins, PfRFC-5 and PfMCM6, as
interactors with Pfmrk. We demonstrate that that these two proteins are substrates of Pfmrk-mediated
phosphorylation and that PfMAT1 confers substrate specificity to the Pfmrk kinase complex. Collectively,
these data suggest a role for Pfmrk in the nucleus of the parasite presumably in regulation of the DNA
replication machinery.
Published by Elsevier B.V.
1. Introduction
Cyclin-dependent kinases are a large group of highly conserved
proteins that play a critical role in the regulation of various cellular
processes such as cell cycle progression, transcription, DNA repli-
cation and repair, apoptosis and differentiation [1]. Active forms
of CDKs are heterodimers comprising of a catalytic Ser/Thr kinase
subunit and a regulatory subunit, usually the cognate cyclin. Bind-
ing of a CDK with its cognate cyclin results in the displacement
of a sterically hindering “T-loop” and exposure of residues in the
catalytic cleft resulting in a partially active enzyme. The action
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of CDK activating kinase (CAK) complex then leads to complete
activation of the CDK-cyclin complex via phosphorylation of a con-
served Thr residue within the “T-Loop” [2]. In metazoans, CDK7
functions as a CAK which phosphorylates and activates cell cycle
CDKs. The CAK complex, which is also involved in the process
of transcription, consists of CDK7, cyclin H and a third stabiliz-
ing partner MAT1 [1]. The MAT1 protein stabilizes and influences
the substrate specificity of the CDK7 kinase complex [3]. Sequence
analysis and biochemical data have revealed that the MAT1 pro-
tein can be divided into three domains with discrete functions: an
N-terminal RING finger domain, a central coiled-coil domain and a
hydrophobic C-terminal domain [4]. The C-terminal domain inter-
acts with the CDK7–cyclin H complex and stimulates CDK7 kinase
activity. The central domain is involved in anchoring the CAK to
the TFIIH core, and the N-terminal domain is involved in CTD phos-
phorylation and transcription activation [4]. The CAK complex has
been shown to be localized in the nucleus and its substrates are
predominantly nuclear [5,6].
Several of these familiar components of the cell cycle regu-
latory machinery have been identified and characterized in the
malaria parasite Plasmodium falciparum [7]. The plasmodial life
0166-6851/$ – see front matter. Published by Elsevier B.V.
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cycle is characterized by alternation between proliferative and
non-proliferative stages. Sporozoites injected into the bloodstream
by an infected Anopheles mosquito migrate to the liver and invade
hepatocytes, producing up to 40,000 merozoites per hepatocyte.
These merozoites are then released into the bloodstream after
lysis of the infected hepatocyte, and in turn invade erythrocytes,
yielding 20–32 daughter merozoites per erythrocyte, which upon
release go on to invade more erythrocytes [8]. Although the
distinct phases of the malaria cell cycle have not been defined,
it is generally accepted that the invading merozoite is in the G1
stage of the cell cycle. At 18h post-invasion, the ring stage parasite
progresses to trophozoite stage and DNA synthesis is thought
to be initiated. Several rounds of asynchronous nuclear division
ensue the trophozoite stage [9]. The exact molecular mechanisms
involved in the regulation of this atypical cell cycle are poorly
understood [10], however they are being actively investigated for
identification of potential novel drug targets.
Several CDKs, cyclins, and a CDK effector protein have been
identified in P. falciparum using homology-based PCR and database
mining approaches [10]. Pfmrk shares 46% sequence identity with
human CDK7 and the recombinant protein phosphorylates RNA Pol
II CTDandHistoneH1 in vitro in thepresence of either human cyclin
H or Pfcyc-1 [11–13]. PfMAT1, a putative homolog of humanMAT1,
stimulates the CTD kinase activity of Pfmrk in a cyclin-dependent
manner in vitro [14]. Although it has been demonstrated that plas-
modial CDKs are amenable to inhibitory mechanisms exerted by
mammalian CDK inhibitors [15], to date CDK inhibitory proteins
have not been identified in Plasmodium. Therefore, the regulatory
mechanisms for activating and inhibiting CDK activity in Plasmod-
ium remain to be unraveled. Furthermore, the substrates of CDKs
and how CDKs regulate the malarial cell cycle are not known.
Pfmrk displays highest similarity to mammalian CDK7; how-
ever it is unclear if Pfmrk is a functional homologue of CDK7
[13]. In metazoans, CDK7 has a dual function as a CAK and as the
kinase element of the general transcription TFIIH complex which
phosphorylates the CTD of RNA polymerase II. In Saccharomyces
cerevisiae, the CDK7 ortholog Kin28 is a CTD kinase and a member
of the TFIIH complexbut doesnot possess CAKactivity. In Schizosac-
charomyces pombe, two CAKs have been found—the Mcs6 complex
and the Csk1 [16]. Hence, CDK7 orthologs from various metazoans
seem to have different biological functions. Therefore, Pfmrk may
have a unique role in the cell cycle that may have arisen through
Plasmodiumevolution. In fact, phylogenetic analyses suggested that
Pfmrk may not belong to the CDK7 family of CDKs [17,18]. Previ-
ous biochemical studies suggested that Pfmrk in association with
Pfcyc-1 or Pfcyc-1-PfMAT1 does not possess CAK activity towards
the CDK1 ortholog PfPK5 [12,14]. Although Pfmrk may function
as a CAK in association with different cyclin subunits or towards
differentplasmodialCDKs, initial inquirieswere raisedas to thebio-
logical function of Pfmrk in the absence of a bona fide CAK activity.
The process of DNA replication is initiated by the action ofmany
enzymes [19]. First, theorigin–recognitioncomplex (ORC) is assem-
bled at the replication origin. This is followed by the recruitment of
the pre-replication complex (pre-RC) consisting of Cdc6, Cdt1and
MCM proteins to the ORC. The MCM2–7 proteins form a hexam-
eric complex that assembles at replication origins during early G1
phase [20]. Coordination of the functional interactions between the
MCM2–7 proteins and other components of the pre-RC is medi-
ated by CDKs [19,21]. Subsequently, loading of DNA polymerase
occurs and is mediated by the replication factor complex (RFC)
[22]. The RFC consists of five members (RFC-1, RFC-2, RFC-3, RFC-
4 and RFC-5). The loading and activation of the pre-RC occurs at
late G1/early S-phase. Once DNA replication is initiated, the Pre-
RC is disassembled thus preventing the re-replication of DNA until
the cell cycle resets again—in the subsequent G1 phase. Sequential
activation and deactivation of CDKs and other cell cycle regulatory
kinases, ensure that the replication of DNAonly occurs once per cell
cycle [23].
Anothermalarial CDK, PfPK5, has been proposed to play a role in
DNA replication [24,25]. PfPK5 expression andkinase activity levels
peak 36h post-invasion and PfPK5 was shown to co-localize with
DNA in the early trophozoite stages, i.e., before or at the onset of
DNA synthesis. Two lines of evidence suggest a role for PfPK5 in the
S-phase (a) elevated PfPK5-associated kinase activity was detected
in parasites treated with the DNA synthesis inhibitor aphidicolin
and (b) treatment of parasites with the PfPK5 inhibitors flavopiri-
dol andolomoucine results in decreasedDNAreplication [26]. Since
no obvious NLSs could be detected in the PfPK5 sequence, the pos-
sibility exists that it is co-transported into the nucleus along with
its cognate cyclin (or other effector) where it regulates DNA repli-
cation. Nuclear import/export of CDKs and cyclins has beendemon-
strated to be a mechanism to regulate cell cycle progression [27].
In this study, we describe the functional characterization of the
P. falciparum CDK Pfmrk. We have validated its interactions with
PfMAT1, demonstrated co-localization to thenucleus and identified
components of the DNA synthesis machinery as substrates of this
enzyme. Taken together, these results suggest a role for Pfmrk in
the DNA replication process.
2. Materials and methods
2.1. Molecular cloning of PfMAT1 deletion mutants
DNA for the construction of PfMAT1 deletion mutants was
amplified from a plasmid template of PfMAT1 full-length cDNA
in pQE30 [14] with oligonucleotides containing a BamHI restric-
tion site. The full-length and truncated PfMAT1 PCR products were
digested with BamHI (Promega) and cloned into the BamHI site of
pET15b (Novagen). All the constructs were sequenced to check for
orientation and correct reading frame.
2.2. Molecular cloning of MBP-PfMAT1
The MBP-tagged version of PfMAT1 was constructed by ampli-
fying PfMAT1 cDNA with oligonucleotides containing EcoRI and
HindIII restriction sites and cloning the PCR product into pMAL-c2X
vector (New England Biolabs).
2.3. Expression and purification of recombinant proteins
Pfmrk (PF10 0141), Pfcyc-1 (PF14 0605), PfMAT1 (PFE0610c),
and RNA Pol II CTD were expressed and purified from Escherichia
coli as GST tagged (Pfcyc-1 and CTD) or 6×His tagged (Pfmrk and
PfMAT1) fusion proteins as previously reported [12,14]. PfRFC-5
was expressed in BL21-CodonPlus-RIL E. coli cells, and purified over
a nickel chelating column under identical conditions previously
described for PfMAT1 [14]. PfRFC-5 purified as a 40kDa protein as
determined by SDS-PAGE. GST-tagged PfMCM6 was purified on a
GSTrapHP column (GEHealthcare) using the sameprotein purifica-
tion procedures as described for Pfcyc-1. GST-PfMCM6 purified as
a110kDa protein as determined by SDS-PAGE. MBP-PfMAT1 pro-
tein was purified on an amylose column (New England Biolabs)
according to the manufacturer’s instructions (www.neb.com).
2.4. Kinase assays
Kinase assays were performed in filter bottommicrotiter plates
as previously described [14]. Briefly, 1.5g of Pfmrk was assayed
in a 50l kinase reaction containing kinase buffer (50mMTris–HCl
pH 7.5, 2.5mMMnCl2, and 1.0mMDTT) supplementedwith 3.0g
Pfcyc-1 and various concentrations of substrates. The reaction was
startedby the additionof anATPmix containing12MATP (Sigma)
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and 5Ci (-32P) ATP, 3000Ci/mmol (Amersham) and activity
assayed at 30 ◦C for 30min. Plates were washed on a vacuumman-
ifold (Whatman) with 5% phosphoric acid. Following the wash,
scintillation fluid was added to each well and activity measured in
a Topcount microtiter plate scintillation counter (Packard). Phos-
phorylation of PfMCM6 was determined using a Kinase-Glo assay
system (Promega) with the same assay conditions as above. Each
assay was performed in triplicate and average kinase activity plot-
ted as relative kinase activity as a percentage above background
(kinase alonewithout substrate). For autoradiography, kinase reac-
tions as described above were assayed under identical conditions
described, however, following the incubation time, the reaction
was stopped by the addition of 4× SDS loading buffer and boiled.
The reactions were resolved on a 12% SDS-PAGE, transferred to
nitrocellulose, and exposed to X-ray film.
2.5. Pull-down assays
2.5.1. Detection of proteins bound to immobilized GST-Pfcyc-1
10g ofGST-Pfcyc-1was incubatedwith 500L of immobilized
glutathione (Pierce) previously pre-incubated with Wash Buffer
(1:1 of 1×PBS:ProFound Lysis Buffer fromPierce) at 4 ◦Cona rotary
shaker for 1h. The sepharose beads were then washed five times
with 1mLWash Buffer and incubatedwith 5g of various proteins
at 4 ◦C on a rotary shaker for 1h. Following incubation, the beads
were washed five times withWash Buffer and boiled with 2× SDS-
PAGE gel loading buffer [28] for 5min and subjected to SDS-PAGE.
Western Blotting was performed using PVDF membranes (Pierce)
according to themanufacturer’s instructions. Anti-His-HRP (Pierce)
at 1:5000 and anti-MBP-HRP (New England Biolabs) antibodies at
1:25,000 were used to detect Pfmrk and PfMAT1, respectively.
2.6. Detection of proteins bound to immunoprecipitated
MBP-tagged PfMAT1
For co-immunoprecipitation reactions, 5g of each protein in
the reaction was allowed to incubate on ice for an hour with
frequent mixing. The proteins were then incubated with 500L
anti-MBP-antibody (New England Biolabs) previously diluted to
1:5000 in Co-IP buffer (50mM Tris pH 7.5, 250mM NaCl, 5mM
EDTA, 0.1% NP-40) at 4 ◦C on a rotary shaker for 1h. 100L of a 50%
slurryof ProteinA-agarose (Sigma) resuspended inCo-IPbufferwas
added and incubated at 4 ◦C on a rotary shaker for 1h. The beads
were then washed five times with 1mL Co-IP buffer and boiled
with 2× SDS-PAGE gel loading buffer for 5min and subjected to
silver staining (Pierce).
2.7. Creation of GFP-tagged Pfmrk and RFP-tagged PfMAT1
constructs
In order to construct the pCHDR–Pfmrk-GFP (the HPG plasmid),
Pfmrk cDNA [14] was first cloned into the pENTR/D-TOPO vector to
create the Pfmrk–pENTR plasmid according to the instructions out-
lined in the Invitrogen GATEWAY manual (www.invitrogen.com).
Pfmrk–pENTR, the GFP tag in the pDONRP2R-P3 vector, the HSP86-
5′promoter in pDONRP4-P1R, and the pCHDR-3/4 destination
vector [29] were combined in an LR reaction (according to proto-
cols outlined in the GATEWAYmanual from Invitrogen). In order to
construct the pHBIL–PfMAT1-RFP (the HMR plasmid), the PfMAT1
cDNA was cloned into the pENTR/D-TOPO vector to create the
PfMAT1–pENTR plasmid. The PfMAT1–pENTR plasmid, the RFP tag
in the pDONRP2R-P3 vector, the HSP86-5′promoter in pDONRP4-
P1R, and the pHBIL-3/4 destination vector [29] were combined in
another LR reaction. The recombinant plasmids were propagated
in E. coli and extracted by Maxi-prep (QIAGEN) columns for trans-
fection of P. falciparum cultures.
2.8. Transfection of P. falciparum
Synchronized P. falciparum strainW2parasites cultured in com-
pletemediumat 5%hematocrit and 7%parasitemia (predominantly
rings) were used for transfection. Prior to electroporation, a 5ml
infected red blood cell (RBC) suspension was centrifuged at 1500g
at 4 ◦C and placed on ice. About 100g of plasmid DNA dis-
solved in 200L of 2× sterile PBS was mixed with the 400l
of the cell suspension in a pre-chilled 0.2 cm cuvette. Electropo-
ration was performed in a BTX electroporation system at 320V,
186 resistance and950F capacitance. Parasiteswere first trans-
fectedwithpCHDR–Pfmrk-GFP (HPG) andcultured in25mLculture
flasks for 48hwithout drug selection. Thereafter, the selection drug
WR992210 was introduced in the culture medium at 2.5ng/mL.
Drug resistant, GFP-fluorescing parasites appeared in 21–25 days
post-transfection. These Pfmrk-GFP expressing parasiteswere then
transfected with pHBIL–PfMAT1-RFP (HMR) and selected for BSD
at 2ng/mL. Drug-resistant parasiteswere established after 2weeks
of continuous culture and maintained on dual drug (WR99210 and
BSD) selection for downstream microscopy studies.
2.9. Fluorescence microscopy on Pfmrk-GFP and PfMAT1-RFP
parasites
Infected RBCs were centrifuged and washed twice with 1× ice-
cold PBS. The pelleted RBCs were then stained with Hoescht 33258
(Invitrogen, 1mg/mL in ice-cold PBS) for 20min in the dark on
a low-speed shaker. The RBCs were pelleted once again, washed
twice with ice-cold 1×PBS, pelleted and placed on to microscope
slides with cover slips. The parasites were visualized for the fluo-
rescence generated by Hoescht, GFP and RFP in an Olympus BX51
fluorescence microscope and the images were captured with a
QImagingRETIGA-2000RVFAST1394digital camerausing theQIm-
agePro software.
2.10. BacterioMatch two-hybrid screen
The expression of the highly conserved malarial CDKs is toxic
to yeast (Personal Communication, Doug Lacount). Therefore, we
chose to employ a bacterial two-hybrid screen to identify proteins
that interactwith Pfmrk rather than themore frequently used yeast
two-hybrid system. A bacterial two-hybrid system (BacterioMatch
II, Stratagene) was used to identify regulatory proteins and sub-
strates of Pfmrk. We constructed a two-hybrid cDNA library from
P. falciparum strain 3D7 cultures consisting of 80% trophozoites
and 20% rings and schizonts. The cDNA library was size fraction-
ated from 400bp to 3kb and cloned into the pTRG target vector
according to the manufacturer’s instructions (Statagene). Pfmrk
served as the bait in the screen and was cloned into the EcoRI
and BamHI sites of the pBT vector according to the manufacturer’s
protocol.
After screening forhistidineauxotrophyandstreptomycin resis-
tance, several positive clones were selected. These clones were
sequenced and a BLAST [30] analysis was performed against the
plasmodial genome database (Plasmodb.org). Results from our
BLAST search yielded several proteins that have been shown to
interact with CDKs in other organisms (Table 1). All two-hybrid
interactions were verified in at least three independent clones.
From our list of four two-hybrid hits, we selected the already
characterizedmini chromosomemaintenance protein-6 (PfMCM6)
(PF13 0291) [31] and the replication factor complex subunit five
(RFC-5) (PF11 0117) for further analyses. Full length PfRFC-5 and
PfMCM6 were subsequently cloned into the pTRG vector via RT-
PCR and their interactions with Pfmrk were confirmed through a
positive validation two-hybrid screen (Stratagene).
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Table 1
List of proteins found to interact with the “Pfmrk bait” in the bacterial two-hybrid system.
PlasmoDB ID Gene name Amino acid sequence of the insert Implicated in biological process Identifiable motifs
PF13 0291 PfMCM6 GALMYADQGICCIDEFDKMDEKDRVAIHEAMEQQTISITKAGI-
QATLNARASVLAACNPKYGRYDTLKTFAQNVNIPA
DNA replication DNA-dependent ATPase
PF11 0117 PfRFC-5 SKTPMYRIFVFKDAEFLSEGAQAGLRRTLETYIRNARVILHLE-
HLSKIIEPLKSRCICIRVPLPSEEEIYSVLQNICKQE
DNA replication ATP/GTP binding
PF11 0232 Hypothetical Protein KDNIYACCHIELSTPYLVKAYINVPC Unknown Cyclin binding
PF07 0126 Hypothetical Protein RERAVSCRKQAEKLFNLPEIQPRNRWNQIKVNGTSHIKKAA-
KLPRCEGIGYDELSQSWVSTFVVHKKF
Transcription AP2 DNA binding
2.11. Cloning of PfMCM6 and PfRFC-5
PfMCM6 was amplified by polymerase chain reaction from
P. falciparum strain 3D7 cDNA using forward primer 5′-
GGGAATTCTCAGCTATATTTAATGAAAGTGAATTATC-3′ and reverse
primer 5′-GGGAATTCTTAAAAATTGTCAATTTC TTCTTG-3′, digested
with EcoRI and cloned into pGEX-5X-3 (GE Healthcare). This
cloning step incorporated a GST tag at the 5′ end of the
PfMCM6 gene. PfRF-C5 was amplified by polymerase chain reac-
tion from P. falciparum strain 3D7 cDNA using forward primer
5′-GGGGATCCATGTGGCTTGAAAAATATAGC-3′ and reverse primer
5′-GGCTGCAGTTATTTTCCATGTAAATTATATTTC-3′. This step facili-
tated subcloning of PfRFC-5 into the BamHI and PstI sites of the
pQE-30—the 6×His tagged expression vector (Qiagen).
3. Results
3.1. The C-terminal hydrophobic domain of PfMAT1 is sufficient
to activate Pfmrk–Pfcyc-1 kinase activity
The PfMAT1 protein sequence displays an overall sequence sim-
ilarity of 49% to human MAT1 [14]. Human MAT1 contains several
domains responsible for its diverse biological functions; in particu-
lar, the C-terminal domain stimulates CDK7 activity [4]. In order
to determine if the analogous domain of PfMAT1 is involved in
activating Pfmrk, we created truncated versions of PfMAT1 and
investigated their ability to activate Pfmrk together with Pfcyc-1 in
an in vitro kinase assays (Fig. 1A). The C-terminal region of PfMAT1
comprising of the hydrophobic domain (amino acids 150–260)
Fig. 1. (A) Schematic drawing of PfMAT1. The ring finger domain (1–51), the coiled-coil domain (112–150) and hydrophobic domain (150–260) are shown. N- and C-terminal
truncations (PfMAT1/51–150, PfMAT1/150–260, PfMAT1/112–260 and PfMAT1/1–150) are represented. (B) The hydrophobic C-terminus of PfMAT1 stimulates Pfmrk kinase
activity. The ability of PfMAT1 truncated mutants to activate Pfmrk activity was evaluated. Kinase reactions containing 1.5g of Pfmrk, 3.0g Pfcyc-1 and 2.0g CTD were
assayed in the presence of 1.5g of full-length and various PfMAT1 truncated mutants. Pfmrk kinase activity and the extent of CTD phosphorylation was determined by
microtiter plate scintillation measurements and autoradiography, respectively.
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Fig. 2. (A) PfMAT1 binds to Pfmrk and Pfcyc-1. Various proteins (MBP-tagged PfMAT1, 6×His-tagged Pfmrk and GST-tagged Pfcyc-1) in the reaction were mixed, immuno-
precipitated with anti-MBP antibody bound to protein A-sepharose beads, subjected to SDS-PAGE and silver stained. Arrows identify PfMAT1, Pfcyc-1and Pfmrk. (B) PfMAT1
binds to immobilized Pfcyc-1 in the presence and absence of Pfmrk. PfMAT1 (MBP-tagged) and Pfmrk (6×His-tagged) were allowed to bind Pfcyc-1 (GST-tagged) bound to
immobilized glutathione beads. Immunoblot analysis was performed with anti-MBP-HRP in order to detect MBP-PfMAT1. (C) Pfmrk binds to Pfcyc-1 only in the absence of
PfMAT1. PfMAT1 (MBP-tagged) and Pfmrk (6×His-tagged) were allowed to bind Pfcyc-1 (GST-tagged) bound to immobilized glutathione beads. Immunoblot analysis was
performed with anti-His-HRP in order to detect Pfmrk.
was sufficient to stimulate Pfmrk activity 4–5-fold (Fig. 1B). The
segment of PfMAT1 lacking the C-terminal hydrophobic region,
however, failed to stimulate Pfmrk activity (Fig. 1B). Hence, we
conclude that the Pfmrk activation domain lies in its hydrophobic
C-terminus.
3.2. PfMAT1 physically interacts with Pfmrk and Pfcyc-1
In order to examine the nature of interactions between PfMAT1,
Pfmrk and Pfcyc-1, pull-down assays were performed as follows.
MBP-PfMAT1 was mixed with Pfmrk in the presence or absence of
Pfcyc-1, and immunoprecipitatedwithanti-MBPantibodybound to
protein-A-sepharose. The immunoprecipitated proteins were then
visualizedwith silver staining. PfMAT1was found to bind indepen-
dently to both Pfmrk and Pfcyc-1 (Fig. 2A). A control experiment
consisting of the MBP tag alone instead of MBP-PfMAT1 did not
pull down any of the proteins used in the experiment (data not
shown).
To further characterize the interactions between these three
proteins, GST-tagged Pfcyc-1 (or the control GST tag) was bound
to immobilized glutathione and its ability to bind to PfMAT1 and
Pfmrk was examined. PfMAT1 was found to bind to immobilized
Pfcyc-1 in the presence and absence of Pfmrk (Fig. 2B). Pfmrk, how-
ever binds to immobilized Pfcyc-1 only in the absence of PfMAT1
(Fig. 2C). The GST tag did not bind Pfmrk or PfMAT1 (data not
shown). These results suggest that Pfmrk, Pfcyc-1 and PfMAT1 can
independently interact with each other; however, we were unable
to detect a trimeric complex presumably due to our experimental
conditions.
3.3. Pfmrk and PfMAT1 co-localize to the nucleus
In an attempt to understand the cellular function of Pfmrk and
to assess the nature of its interaction with its effector PfMAT1 in
vivo,we constructed Invitrogen’sGATEWAY-based [29]GFP-tagged
version of Pfmrk (HPG) and RFP-tagged version of PfMAT1 (HMR)
under the control of the P. falciparum Hsp86 promotor (Fig. 3A
and B). We resorted to this approach due to the lack of availabil-
ity of high-quality antibodies to both Pfmrk and PfMAT1. We were
unable to use the antibodies generated against Pfmrk (generated
against the Pfmrk peptide sequence MENNSTERYIFK) and PfMAT1
(generated against thePfMAT1peptide sequenceCYQNERKKIHEIV-
KEEG) for our immunofluorescence analyses, since these antibodies
failed to identify the corresponding proteins on western blots
from parasite protein extracts (data not shown). Hence, in an
effort to express tagged versions of these proteins, W2 P. falci-
parum parasites were transfected with the HPG plasmid (Fig. 3A)
and transfectants were selected on medium containing WR99210.
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Fig. 3. GATEWAY-based constructs used to transfect parasites. (A) Hsp86 promoter driven Pfmrk-GFP fusion construct (HPG). (B) Hsp86 promoter driven PfMAT1-RFP
construct (HMR).
Expression of Pfmrk-GFP fusion protein (68kDa) in the transgenic
parasites was confirmed by immunoblotting using anti-GFP anti-
bodies (Fig. 4A). In order to determine the intracellular location of
Pfmrk-GFP, fluorescence microscopic analyses were performed on
these transgenic parasites. The intracellular fluorescence pattern
of Pfmrk-GFP coincided with nuclear staining observed with the
DNA-staining dye Hoechst 33228 suggesting that Pfmrk is local-
ized in the nucleus (Fig. 4B). Next, W2 parasites expressing the
HPG plasmidwere transfectedwith theHMRplasmid (Fig. 3B)with
the aim of generating parasite cells co-expressing both Pfmrk-GFP
and PfMAT1-RFP. Transgenic parasites harboring both plasmids
were selected on medium containing both WR99210 and BSD.
Fig. 4. Analysis of HPG and HPG; HMR transgenic lines. (A) Western blot depicting the expected 68kDa Pfmrk-GFP protein in crude HPG extracts. (B) GFP and Hoescht
fluorescence in ring, trophozoite, early schizont and late schizont stages in the HPG-expressing parasites. (C) GFP, RFP and Hoescht fluorescence observed in schizonts of the
HPG and HMR co-expressing parasites.
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Fig. 5. CLUSTAL W alignment of RFC-5 subunits from Drosophila melanogaster (NM 135650.2), Schizosaccharomyces pombe (NP 595646.1) and Plasmodium falciparum
(PF11 0117). Identical amino acids are depicted in bold. The predicted motifs in PfRFC-5 are indicated in color and highlighted. Residues 40–47 (in red) correspond to
the “WalkerA” motif, residues 41–48, 132 and 161 (highlighted) are predicted to fall within the ATP-binding site, residues 128–133 (in purple) correspond to the “WalkerB
motif” and residue 175 (in blue) corresponds to the “Arginine finger”. The amino acid numbers for PfRFC-5 are indicated to the right. (For interpretation of the references to
color in this figure legend, the reader is referred to the web version of the article.)
Microscopic analyses of these double transfectants revealed fluo-
rescence signals in thenucleuspredominantly in schizonts (Fig. 4C).
This observation suggests that Pfmrk and PfMAT1 are localized
to the parasite’s nucleus, although the RFP fluorescence is more
extended suggesting that PfMAT1 may not be strictly localized in
the nucleus. Pfmrk and PfMAT1 expressed from a PfCRT (P. falci-
parum chloroquine resistance transporter) promoter [29] in the
sameGATEWAYvectorsdisplayedasimilar intracellular expression
pattern (data not shown). The PfCRT promoter is weaker compared
to the PfHsp86 promoter and is considered useful in expressing
transgenes that are toxic to parasites when expressed in higher
levels and does not necessarily result in nuclear localization of
transgenes [29]. Hence, it is not unreasonable to conclude that
the nuclear localization of Pfmrk and PfMAT1 observed in the dual
HPG, HMR lines is a representation of their true native state. Inter-
estingly, we observed the GFP signal for Pfmrk throughout the
different intraerythrocytic developmental stages of the parasites,
however for PfMAT1-RFP, we were only able to observe the RFP
signal in the schizonts. This suggests that PfMAT1 protein stability
might be cell cycle-stage dependent.
3.4. PfRFC-5 and PfMCM6 interact with Pfmrk in the bacterial
two-hybrid system
To date little is known about the in vivo substrates of malar-
ial CDKs. Hence, in order to identify substrates of Pfmrk, we
performed a bacterial two-hybrid screen on a cDNA library pre-
pared from P. falciparum using Pfmrk as the bait. Four proteins
PF13 0291 (PfMCM6), PF11 0117 (PfRFC-5), PF11 0232 (hypothet-
ical protein) and PF07 0126 (hypothetical protein) were found
to interact with Pfmrk (Table 1). Of these, we chose to focus
on PfRFC-5 and PfMCM6 for further investigations. PfRFC-5 dis-
plays an overall sequence similarity of 30% to replication factor
complex subunits from Drosophila and yeast (Fig. 5). The RFC
(replication factor complex) is a complex of five subunits highly
conserved in all eukaryotes. RFC loads the “sliding clamp” PCNA
(proliferating cell nuclear antigen) onto DNA during replication.
The loading of PCNA onto DNA by RFC is an important step
in DNA replication and increases the processivity of DNA poly-
merase [32]. The RFC subunits share eight regions of high sequence
similarity that include regions involved in protein complex forma-
tion, DNA binding, PCNA binding and DNA replication [32]. The
motifs identified in PfRFC-5 when queried on the NCBI Entrez
website (http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi)
include (i) an ATP-binding site encompassing residues 41–48 and
residues 132 and 161, (ii) the WalkerA motif {consensus sequence
GxxGxGK(S/T)} encompassing residues 40–47, (iii) the WalkerB
motif consensus {contains four aliphatic residues followed by two
negatively-charged residues}, encompassing residues128–133and
(iv) an Arginine finger, residue 175 (Fig. 5). RFC proteins belong to
the AAA+ superfamily of ATPases that contain a P-loop NTPase fold.
TheWalkerA domain forms a loop that binds to the alpha and beta
phosphatemoieties of the bound nucleotide and theWalkerBmotif
is important for interactingwithMg2+ cation. The Arginine finger is
an AAA+-family specific motif that senses ATP binding and hydrol-
ysis and transmits conformational changes [33]. The RFC clamp
loader has been shown to require the Arginine finger sensors (ema-
nating from each of the subunits) to drive DNA binding and loading
of the PCNA [34].
Another interactor of Pfmrk, PfMCM6 (P. falciparum mini-
chromosomemaintenance 6), has been characterized as a member
of a hexameric pre-replication complex (pre-RC). The MCM com-
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Fig. 6. PfMCM6 and PfRFC-5 are substrates of Pfmrk. Kinase assays were performed
with 1.5g Pfmrk and 3.0g Pfcyc-1 with various substrates of either 2.0g CTD,
2.0g PfRFC-5, 2.0g PfMCM6 or Histone H1 in the absence or presence of 3.0g
PfMAT1. Each assay was performed in triplicate and average kinase activity plotted
as relative kinase activity.
plexhasbeen showntoplayakey role in the transitionof thepre-RC
to the RC and is known to function as a replicative helicase [19].
PfMCM6was shown to be associatedwith chromatin at every stage
of the parasite’s intraerythrocytic life stage [31].
3.5. Pfmrk phophorylates PfRFC-5 and PfMCM6 in vitro
Subunits of the RFC and MCM complex are phosphorylated
by CDKs and their phosphorylation status might affect their sub-
cellular localization and their ability to bind DNA and other
subunits [21,35,36]. To determine whether PfRFC-5 and PfMCM6
are substrates of Pfmrk, in vitro phosphorylation assays were per-
formed. Pfmrk was found to phosphorylate both PfRFC-5 and
PfMCM6 in vitro (Fig. 6). Interestingly, Pfmrk-mediated phospho-
rylation of PfMCM6 was activated by PfMAT1. In the presence of
PfMAT1, Pfmrk kinase activity was stimulated towards the three
substrates—CTD, Histone H1 and PfMCM6. PfRFC-5 seems to be a
good substrate of Pfmrk, however the addition of PfMAT1 did not
stimulate further phosphorylation of PfRFC-5.
4. Discussion
In this study, we have characterized the interactions between
Pfmrk and its effector PfMAT1 in vitro. The data presented from our
co-immunoprecipitation experiments demonstrated stable inter-
actions between PfMAT1 and Pfcyc-1, PfMAT1 and Pfmrk, and
between Pfcyc-1 and Pfmrk. The inability to observe a stable
trimeric complex (Pfmrk–PfMAT1–Pfcyc-1) is most likely due to
our experimental conditions. Co-IP of complexes is sometimes
problematic andmay reflect stearic hindrancedue to the antibodies
or immobilizing supports used in the IP. For example, Rossignol et
al. [37] observed an interaction between CDK7 and cyclin H, CDK7
andMAT1, butwere unable to detect an interaction between cyclin
H and MAT1 and Busso et al. [4] demonstrated a weak interaction
between cyclin H and MAT1 even though a CDK7–cyclin H–MAT1
exist as an in vivo trimeric complex. Although a trimeric complex
with Pfmrk was not detected, previous studies demonstrate that
PfMAT1 stimulates Pfmrk kinase activity in a Pfcyc-1 dependent
manner [14], suggesting the formation of a trimeric complex. The
inability todetect the trimeric complexbyco-immunoprecipitation
using either purified recombinant proteins or parasite extracts
(data not shown), may be indicative that future studies to iden-
tify the complex may have to utilize affinity chromatography
approaches.
Many characteristics of Pfmrk suggest similarities to CDK7. First,
Pfmrk activity is stimulated by the binding of cyclin H or Pfcyc-1
(a cyclin with the greatest sequence identity to the CDK7 cog-
nate cyclin H) [12] and the association of PfMAT1 [14]. Second,
the CTD of RNA polymerase II is a strong substrate of Pfmrk and
third, Pfmrk displays inhibitor sensitivity profiles similar to CDK7
[12,13,38–40]. The present study demonstrates a further similarity
to CDK7 by showing that PfMAT1 interacts with both Pfmrk and
Pfcyc-1. Interaction with both the CDK and cyclin is believed to
stabilize the trimeric complex [41]. The molecular architecture of
PfMAT1 is highly similar to humanMAT1with a ring finger, coiled-
coil and hydrophobic domain. Analogous to the CDK7 complex, our
studies demonstrate that the C-terminal hydrophobic domain of
PfMAT1 is responsible for stimulatingPfmrk activity [4]. The coiled-
coil and ring finger domains of MAT1 are believed to be involved
in protein–protein interactions which may direct the CDK7 com-
plex to specific substrates [3]. In fact, we observe that PfMAT1
influences substrate specificity of Pfmrk. Since the hydrophobic
domain of PfMAT1 activates Pfmrk, it is likely that other PfMAT1
domains may be involved in similar PfMAT1–protein interactions
as observed with mammalian MAT1.
Immunofluorescence analyses show that Pfmrk localizes in the
nucleus along with its effector PfMAT1. This result was surprising
since stretches of basic amino acid sequences representing nuclear
localization signals (NLSs) [42,43] cannot be detected in the amino
acid sequences of Pfmrk. In the case of CDK7, it has been shown that
the KRKR motif is required for nuclear targeting and that mutating
the sequence to NGER retains the protein in the cytoplasm. This
nuclear targeting of CDK7 is necessary to confer the proteinwith its
CAK activity [44]. It is possible that either the NLS signals of these
malarial CDKs are cryptic or these proteins are chaperoned into
the nucleus by other NLS-containing proteins. Cyclin H is targeted
to the nucleus by a C-terminal NLS (KKRKgyedddyvsKKsKh) [45].
Examination of the amino acid sequences of Pfcyc-1 [12], Pfcyc-
2, Pfcyc-3 and Pfcyc-4 [46] reveals the presence of putative NLSs
in Pfcyc-1 (KKKKNSKKSKKKKLDNK) and Pfcyc-2 (RSNIYNGNK). An
NLS has not been identified in the sequences of either hMAT1 or
PfMAT1. Hence, it is tempting for us to speculate that Pfmrk may
bechaperoned into thenucleusbyoneof its cognate cyclinsorother
hitherto unidentified effector(s).
The identification of proteins that interact with Pfmrk provides
evidence for a role in distinct cellular processes. Our studies suggest
that Pfmrk interacts with proteins believed to be involved in gene
expression and DNA replication. One of the hypothetical proteins
identified, PF07 0126 is aputative transcription factor. It remains to
be investigated if this protein is a transcription factor and whether
Pfmrk plays a role in the regulation of gene expression during the P.
falciparum life cycle. It is not surprising that Pfmrk may have a role
in gene expression as CDK7 and orthologs regulate gene expression
in associationwith the basal transcription RNA Pol II TFIIH complex
[16,47]. Additionally, we identified an association of Pfmrk with
regulators of DNA replication, PfRFC-5 and PfMCM6. Inmammalian
cells, MAT1 and the CAK complex have been shown to physically
interact with the MCM proteins suggesting a role for CDK7 in DNA
replication [48]. The interaction with the molecular machinery of
DNA replication and transcription is consistent with the nuclear
localization of Pfmrk.
Subunits of the RFC and MCM complex are substrates of CDKs
[23,49]. In this study, we demonstrated that Pfmrk phosphory-
lates PfRFC-5 and PfMCM6 in vitro. The biological significance of
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this phosphorylation is unclear as CDK phosphorylation has been
shown to be involved in both activation and deactivation of the
DNA replication complexes [50]. The malarial cell cycle operates
under the confines of an endoreduplication process known as
endomitosiswherein S andMphases alternatewithout intervening
cytokinesis [51,52]. Interestingly, even during endoreduplication
(which occurs during differentiation of mammalian trophoblasts
and megakaryoblasts), CDKs are involved in regulating the endo-
cyclic process. In fact, differences in CDK regulation are responsible
formaintaining either a “normal”mitotic cell cycle versus an endo-
cycle by controlling the assembly and firing of the pre-RC [53].
Many components of the pre-RC and RC are encoded in the plas-
modial genome and several have been characterized including
MCMs, ORCs, DNA polymerases and PCNA [31,54–58]. Although
the in vivo phosphorylation status of these DNA replication com-
ponents remains to be investigated, it is tempting to speculate
that Pfmrk-mediatedphosphorylationof PfRFC-5 andPfMCM6may
regulate the initiation of DNA replication. The microarray data of
Pfmrk, PfMAT1 and Pfcyc-1 suggest high levels of expression from
4 to 28h peaking at 8 and 24h—several hours before the start of
DNA replication [59]. PfMCM6 protein has been predominantly
detected in late trophozoites and schizonts, and gene expression
of both PfMCM-6 and PfRFC-5 peaks in late trophozoites through
early schizonts—stages where most DNA replication is thought to
occur [31,60].
In summary, this study shows that Pfmrk physically interacts
with its effector PfMAT1 in vitro and that the C-terminal hydropho-
bic domain of PfMAT1 is the Pfmrk-activating domain. We have
also shown that Pfmrk and PfMAT1 co-localize in the nucleus and
that regulators of DNA synthesis, PfRFC-5 and PfMCM6, are in vitro
substrates of Pfmrk. Hence, we suggest that Pfmrk may play an
important role in malarial DNA replication. Future studies should
be directed toward characterization of the in vivo Pfmrk-effector-
substrate complexes in an effort to validate and correlate Pfmrk
kinase activity with cell cycle mediated DNA replication.
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